A multicenter prospective phase II randomized trial of epirubicin/vinorelbine versus pegylated liposomal doxorubicin/vinorelbine as first-line treatment in advanced breast cancer. A GOIM study (Q34855129)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | A multicenter prospective phase II randomized trial of epirubicin/vinorelbine versus pegylated liposomal doxorubicin/vinorelbine as first-line treatment in advanced breast cancer. A GOIM study |
scientific article |
Statements
1 reference
A multicenter prospective phase II randomized trial of epirubicin/vinorelbine versus pegylated liposomal doxorubicin/vinorelbine as first-line treatment in advanced breast cancer. A GOIM study (English)
1 reference
Patrizia Vici
1 reference
Giuseppe Colucci
1 reference
Gianfranco Filippelli
1 reference
Francesco Giotta
1 reference
Pasquale Perri
1 reference
Claudio Botti
1 reference
Armando Carpino
1 reference
Laura Pizzuti
1 reference
Agnese Latorre
1 reference
Massimo Lopez
1 reference
Luigi Di Lauro
1 reference
12 April 2011
1 reference
1 reference
30
1 reference
39
1 reference
12 April 2011
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference